Small Caps Dashboard
 

PHARMAXIS


Sector: Biotech

Industry: Drug developer

Pharmaxis is an Australian pharmaceutical research company focussed on development drugs for inflammation and fibrotics diseases.

Pharmaxis is developing its drug PXS-5505 for the bone marrow cancer myelofibrosis which causes a build up of scar tissue that leads to loss of production of red and white blood cells and platelets.

 

Other drug candidates being developed from Pharmaxis’ amine oxidase chemistry platform are targeting fibrotic diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis; fibrotic scarring from burns and other trauma; and inflammatory diseases such as Duchenne Muscular Dystrophy.

The company has licenced two products: Bronchitol used to treat cystic fibrosis and marketed in Australia, Europe and Russia with US FDA approval pending; and Aridol, a lung function test for the assessment and diagnosis of asthma, marketed in Asia, Australia, Europe and US. The company has a pipeline of five drugs at various stages of development.

**FY20 Forecast

See our recomndations.
Unlock

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porttitor semper molestie. Ut eleifend, erat eu pulvinar iaculis, odio nunc venenatis tellus, ut placerat lorem purus sed tellus. Duis ut leo vitae massa facilisis dictum sed a dui. Proin quis pulvinar purus, vestibulum lobortis justo.

 
  • Radar Rating Unlock
  • Market Cap ($m)* 41.7
  • Dividend Yield (%)* 0
  • NET CASH ($M) 11
  • * Data as of 18 January 2022

Latest Research Summary

PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2020
05 Nov, 2020

Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Maecenas ut ex et est semper fringilla. Nam et lectus augue. Integer non consectetur ligula. Maecenas tortor metus, molestie at aliquam sit amet, feugiat sed ipsum. Donec vehicula mi ac neque tempor dignissim.

Unlock to view the latest research

Previous Research

Research Date Radar Rating  
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2020 05 Nov, 2020 91b65849 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2020 15 Jul, 2020 6db6179d View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2020 402 02 Jul, 2020 a6414327 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JANUARY 2020 16 Jan, 2020 7a0bdd88 View Research
PHARMAXIS: RESEARCH TIP UPDATES - AUGUST 2019 21 Aug, 2019 2a52daf3 View Research
PHARMAXIS: RESEARCH TIP UPDATES - MAY 2019 08 May, 2019 f8471115 View Research
PHARMAXIS: RESEARCH TIP UPDATES - FEBRUARY 2019 06 Feb, 2019 498fee3b View Research
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2018 21 Nov, 2018 90cd2d54 View Research
PHARMAXIS: RESEARCH TIP UPDATE - OCTOBER 2018 24 Oct, 2018 2b6c5a1d View Research
PHARMAXIS: RESEARCH TIP UPDATES - AUGUST 2018 08 Aug, 2018 990a9a13 View Research
PHARMAXIS: HEALTH AND BIOTECH - APRIL 2018 05 Apr, 2018 389f085e View Research
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2017 08 Nov, 2017 ec25b646 View Research
PHARMAXIS: RESEARCH TIP UPDATE - SEPTEMBER 2017 14 Sep, 2017 899d9e86 View Research
PHARMAXIS: REPORTING SEASON - AUGUST 2017 17 Aug, 2017 07b48dc0 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2017 06 Jul, 2017 320d8262 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JUNE 2017 15 Jun, 2017 e1fc00cb View Research
PHARMAXIS: RESEARCH TIP UPDATE - MAY 2017 18 May, 2017 9790918e View Research
PHARMAXIS: BIOTECH SPECIAL REPORT - FEBRUARY 2017 08 Feb, 2017 dd42d85c View Research
PHARMAXIS: RESEARCH UPDATE - AUGUST 2016 25 Aug, 2016 f184c086 View Research
PHARMAXIS: INITIAL - MARCH 2016 29 Mar, 2016 6ed19f50 View Research
PHARMAXIS 25 Sep, 2014 7e829b15 View Research
PHARMAXIS 22 Feb, 2014 ff2eea58 View Research
PHARMAXIS 13 Jun, 2013 4e814c95 View Research